Healthcare entity
market-trends is the sole category represented across all 1 tracked stories. Of the tracked stories, 1 of 1 also mention Eli Lilly, the most common co-covered peer. They are less corroborated than the beat average, carrying 2 original sources each against 12.7 for the same window.
Last mentioned: Jul 16, 2026
Entity pulse
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
market-trends is the sole category represented across all 1 tracked stories. Of the tracked stories, 1 of 1 also mention Eli Lilly, the most common co-covered peer. They are less corroborated than the beat average, carrying 2 original sources each against 12.7 for the same window. Their average consequence score of 5 runs below the beat's 6.6 for that window. We currently track 1 Healthcare story that mention S&P 500, all published on June 28, 2026.
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 21 Healthcare stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering S&P 500. Shared-story counts are live from our verified record — not editorial picks.
While Pfizer's huge dividend captivates income investors, healthcare leaders should watch for clinical pipeline shortfalls. The 2025 GLP-1 withdrawal signals reliance on an aging blockbuster portfolio as patents approach expiry.
S&P 500 is linked from 1 story on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.
